Can-Fite
Pre-Approval PRO BETAPipeline by Phase
Therapeutic Focus
Clinical Trials (19)
Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis
Started: 3/15/2023
A Phase 3 Study in Moderate-to-Severe Plaque Psoriasis With Piclidenoson to Study Safety and Efficacy
Started: 6/1/2025
Trial of CF101 to Treat Patients With Dry Eye Disease
Started: 7/1/2011
CF101 Therapy in Patients With Moderate-to-severe Plaque Psoriasis
Started: 9/15/2018
CF101 Therapy Compared to Methotrexate Therapy for Active Rheumatoid Arthritis
Started: 10/30/2017
Namodenoson Treatment of Advanced Pancreatic Cancer
Started: 11/10/2024
Namodenoson in the Treatment of Non-Alcoholic Steatohepatitis (NASH)
Started: 12/10/2021
An Open-label, Phase 2 Pilot Study on the Efficacy and Safety of Piclidenoson in Patients With Lowe Syndrome
Started: 6/1/2026
Phase 2, Randomized, Double-Blind, Placebo-Controlled of the Efficacy and Safety of CF102 in Hepatocellular Carcinoma (HCC)
Started: 9/1/2014
Oral CF101 Tablets Treatment in Patients With Rheumatoid Arthritis
Started: 10/1/2010
Safety and Efficacy of Daily CF101 Administered Orally in Subjects With Elevated Intraocular Pressure
Started: 10/1/2010
A Study of the Efficacy and Safety of CF102 in the Treatment of Non-Alcoholic Fatty Liver Disease
Started: 11/27/2017
Oral CF101 Tablets and Methotrexate Treatment in Rheumatoid Arthritis Patients
Started: 2/1/2008
A Study of the Efficacy and Safety of CF101 to Patients With Osteoarthritis of the Knee
Started: 11/1/2018
A Phase 1-2 Study of CF102 in Patients With Advanced Hepatocellular Carcinoma
Started: 2/1/2009
A Phase 1/2 Study of CF102 in Patients With Chronic Hepatitis C Genotype 1
Started: 7/1/2009